1,3,5-trinitrobenzene structure
|
Common Name | 1,3,5-trinitrobenzene | ||
|---|---|---|---|---|
| CAS Number | 99-35-4 | Molecular Weight | 213.10500 | |
| Density | 1.705g/cm3 | Boiling Point | 315ºC at 760mmHg | |
| Molecular Formula | C6H3N3O6 | Melting Point | 122°C | |
| MSDS | Chinese USA | Flash Point | 164.1ºC | |
| Symbol |
GHS01, GHS06, GHS08, GHS09 |
Signal Word | Danger | |
| Name | 1,3,5-trinitrobenzene |
|---|---|
| Synonym | More Synonyms |
| Density | 1.705g/cm3 |
|---|---|
| Boiling Point | 315ºC at 760mmHg |
| Melting Point | 122°C |
| Molecular Formula | C6H3N3O6 |
| Molecular Weight | 213.10500 |
| Flash Point | 164.1ºC |
| Exact Mass | 213.00200 |
| PSA | 137.46000 |
| LogP | 2.98080 |
| Index of Refraction | 1.655 |
| InChIKey | UATJOMSPNYCXIX-UHFFFAOYSA-N |
| SMILES | O=[N+]([O-])c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS01, GHS06, GHS08, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H201-H300 + H310 + H330-H373-H410 |
| Precautionary Statements | P260-P264-P273-P280-P284-P301 + P310 |
| Target Organs | Blood, Central nervous system, Liver |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | E,T+,N,T,F |
| Risk Phrases | R1 |
| Safety Phrases | S35-S45-S60-S61-S27-S16-S36/37-S24/25-S23-S53 |
| RIDADR | 1354 |
| RTECS | DC3850000 |
| Packaging Group | II |
| Hazard Class | 1.1D |
| HS Code | 2904209090 |
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2904209090 |
|---|---|
| Summary | 2904209090 derivatives containing only nitro or only nitroso groups。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |
|
Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.
World J. Gastroenterol. 20(31) , 10876-85, (2014) To investigate the beneficial effect of the combination of butyrate, Lactobacillus casei, and L-carnitine in a rat colitis model.Rats were divided into seven groups. Four groups received oral butyrate... |
|
|
Biochemical and histopathological evidence on the beneficial effects of Tragopogon graminifolius in TNBS-induced colitis.
Pharm. Biol. 53(3) , 429-36, (2015) Tragopogon graminifolius DC. (Compositae) (TG) has been proposed as an efficacious remedy for gastrointestinal ulcers in Iranian traditional medicine.The present study evaluates the efficacy of TG on ... |
|
|
Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Int. J. Pharm. 480(1-2) , 116-27, (2015) In the present study, we constructed a tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier containing paclitaxel (FA-BSA-LC/DOPE-PTX), by adding 1,2-dioleoyl-sn-glycero-3-phosphoethanolamin... |
|
Name: Carcinogenesis bioassays from the Carcinogenic Potency Database (CPDB)
Source: 25294
Target: N/A
External Id: cpdb
|
| EINECS 202-752-7 |
| MFCD00059179 |
| 1,3,5-TRINITROBENZENE |